Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

84.70 -1.00 (-1.17%)
Official Closing Price Updated: 4:10 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,673,379
Open 85.38
Bid (Size) 84.50 (1)
Ask (Size) 85.00 (3)
Prev. Close 85.70
Today's Range 84.15 - 85.68
52wk Range 73.31 - 111.58
Shares Outstanding 2,531,374,696
Dividend Yield 3.83%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential
Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least $5 billion. 
Via Benzinga
Can $10,000 in Merck Stock Turn Into $50,000 by 2030?
The pharmaceutical giant has seen brighter days. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
-14.6%
-14.6%
1 Month
+4.5%
+4.5%
3 Month
+1.2%
+1.2%
6 Month
+7.0%
+7.0%
1 Year
-22.8%
-22.8%

More News

Read More
Absci's AI Revolution: A New Era for Drug Discovery or a Rocky Road Ahead?
Via MarketMinute
Topics Artificial Intelligence
1 Cash-Producing Stock to Target This Week and 2 That Underwhelm
Via StockStory
2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk
Via MarketBeat
Topics Artificial Intelligence
Dow Jones Soars on Trump's Tariff Remarks, Signaling Market Volatility Amidst Trade Policy Shifts
Via MarketMinute
Topics Economy Government Stocks
Tesla To $300? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest?
Via The Motley Fool
Topics ETFs Government World Trade
Inflation's Shadow Lengthens: September CPI Ignites Fed Caution Amidst Government Shutdown
Via MarketMinute
Topics Bonds Economy World Trade
Global Markets Diverge: Asian Shares Stumble Amid US-China Trade Tensions, While Wall Street Futures Rebound
Via MarketMinute
Topics Artificial Intelligence Economy Government
UK Weighs 25% Rise In Drug Prices As Pharma Giants Pause Investments
Via Benzinga
Pfizer (NYSE:PFE) Marks 348th Consecutive Dividend Payment: A Pillar of Stability Amidst Transformation
Via MarketMinute
Topics Artificial Intelligence Economy Government
Zoetis (NYSE:ZTS) Signals Robust Health with Q4 2025 Dividend Declaration, Bolstering Investor Confidence in Animal Health Sector
Via MarketMinute
Topics Economy
Zoetis (NYSE:ZTS) Declares $0.50 Q4 2025 Dividend, Signaling Robust Animal Health Market
Via MarketMinute
Pfizer's 348th Consecutive Dividend: A Beacon of Stability Amidst Industry Headwinds
Via MarketMinute
Topics Economy Intellectual Property Retirement
Behind the Scenes of Merck & Co's Latest Options Trends
Via Benzinga
5 Healthcare Plays Powering the Sector’s Big Comeback
Via MarketBeat
Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025
From Merck & Co., Inc.
Via Business Wire
Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025
From Merck Sharp & Dohme
Via Business Wire
MERCK INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Merck, Doctors Reject Proposal To Break Up Combined MMR Vaccine
Via Benzinga
How Arcus Biosciences Aims To Take On Merck In Cancer Treatment
Via Investor's Business Daily
Merck Completes Acquisition of Verona Pharma
From Merck & Co., Inc.
Via Business Wire
Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases
From Merck Sharp & Dohme
Via Business Wire
1 Monster Stock in the Making to Buy and Hold
Via The Motley Fool

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 84.70
When was Merck & Co last traded?
The last trade of Merck & Co was at 10/14/25 04:10 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 214.41B
How many shares of Merck & Co are outstanding?
Merck & Co has 214B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.